SAGILITY Q2 FY27 Results & Earnings Analysis
Sentiment: Good (Confidence: high)
Earnings Summary
Sagility delivered strong Q2 FY27 with revenue growth of 22.5% YoY in INR (12.2% CC) and organic growth of 22.2% INR (11.9% CC). Adjusted EBITDA margin expanded to 26.3%, highest in six quarters, driven by operating leverage, efficiencies, FX, and geo mix. Adjusted PAT grew 8.1% to INR 3,254M. Raised FY27 adjusted EBITDA margin guidance to 25-26% and maintained low double-digit organic revenue growth guidance. Announced Chirok acquisition ($20M upfront + up to $12.35M earnout) to strengthen provider segment mid-cycle RCM capabilities. Net cash position of INR 1,127M. Key risks: lower open enrollment revenue, wage inflation, provider growth tapering. Overall positive outlook with balanced growth and margin focus.
Management Tone
- Prepared Remarks: Good — Management highlighted robust Q2 performance with 22.5% revenue growth, 23% EBITDA growth, margin expansion to 26.3%, and raised guidance. Also announced strategic acquisition and dividend. Tone confident and forward-looking.
- Q&A Session: Good — Analysts congratulated on strong profitability; management provided detailed responses on margin levers, acquisition strategy, and open enrollment trends. Some questions on Chirok revenue per headcount and ACV split were deferred, but overall informative.
Revenue Growth Drivers
- Steady-state business growth and expansion within existing client relationships
- New deal wins including large payment integrity engagement ($10M+ ACV)
- CareSeed acquisition contribution (excluded from organic)
Growth vs Margin Focus
Management raised margin guidance while maintaining low double-digit organic revenue growth guidance. Emphasized balancing growth investment with sustainable profitability, and stated long-term margin range of 24-26% while trying to accelerate top-line growth.
About Sagility Limited
Sagility Limited (SAGILITY) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.